Research Pipeline
– View Pipeline –
Kyocera Riken
Histogen HSC
Shiseido
RepliCel
Samumed
Follica
Aclaris
Allergan Setipiprant
Allergan Bimatoprost
Cassiopea
Studies
Androgenetic Alopecia
Alopecia Areata
Treatments
Diagnostic Methodologies
Alopecia Universalis
Alopecia Totalis
Chemotherapy
New Research
Natural Treatments
Women
Children
Research Methods
Gene Therapy
Hair Transplants
Social
Subscription Options
Show Menu
Home
Alopecia
Alopecia Areata
Alopecia Totalis
Alopecia Universalis
Children’s Hair Loss Guide
Hair Disorders
Men’s Solutions
Hair Loss Treatments
Finasteride Propecia
Minoxidil Rogaine
S5 Cream
S5 Plus Cream
Revivogen MD
Tricomin
Kourosh
Laser Comb
Regenepure
Toppik and Couvre
Hair Transplants
Hair Replacement Systems
Women’s Solutions
Women’s Hair Loss Treatments
News
Interact
Discussion Forums
Chat Room
Shop
DHT Inhibitors
Growth Stimulants
Anti-Inflammatories
Concealers
Shampoos
Women’s Treatments
Sale
Menu
Home
Forums
New posts
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Log in
Register
What's new
Current visitors
New profile posts
Menu
Log in
Register
Install the app
Install
Home
Members
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Kagaho's latest activity
K
Kagaho
replied to the thread
Kintor has started Phase 3 trial in China for Pyrilutamide
.
I think it works, at least to some degree. Despite the results from that infamous groupbuy. It is stronger than RU and Breezula, and...
Today at 1:58 AM
K
Kagaho
replied to the thread
Kintor has started Phase 3 trial in China for Pyrilutamide
.
Lol they are doing phase 2 both China and USA, do people realize how costly is that? Maybe it wont be strong enough to replace finasteride but...
Yesterday at 12:21 PM
K
Kagaho
reacted to
Ralph Wiggum's post
in the thread
Kintor has started Phase 3 trial in China for Pyrilutamide
with
Like
.
https://www.hairlosscure2020.com/kintor-pharmaceutical-from-china/ Update: August 11, 2022 — Great news per a Chinese contact. It looks...
Thursday at 2:20 PM
K
Kagaho
replied to the thread
Kintor has started Phase 3 trial in China for Pyrilutamide
.
They have been delaying the publication of the results since february. Its kind of weird. I think its time to reach Kintor and ask them...
Thursday at 12:43 PM
K
Kagaho
replied to the thread
Kintor has started Phase 3 trial in China for Pyrilutamide
.
Well, lets hope they present Pyri results this time. Its going to harm their credibility if they keep postponing.
Wednesday at 11:39 PM
K
Kagaho
replied to the thread
Kintor Pharma Announces Dosing of First Subject in US Phase I Clinical Trial of GT20029 for Androgenic Alopecia and Acne
.
And youre basing this on? Topical antiandrogen do work, even the weaker ones to some extent. KX is expected to have stronger binding...
Aug 6, 2022
K
Kagaho
replied to the thread
Kintor has started Phase 3 trial in China for Pyrilutamide
.
https://www.prnewswire.com/news-releases/kintor-pharma-announces-completion-of-patient-enrollment-in-phase-ii-clinical-trial-of-kx-826-fo...
Aug 3, 2022
K
Kagaho
replied to the thread
Kintor Pharma Announces Dosing of First Subject in US Phase I Clinical Trial of GT20029 for Androgenic Alopecia and Acne
.
A cure as a standalone treatment its way too much for an antiandrogen. Even castrates dont regrow all their hair so why will this drug...
Aug 1, 2022
K
Kagaho
replied to the thread
The Group Buy to End All Group Buys: Twist1 Inhibitor
.
Dude, youre obviously new to this group buy game. Maybe those promoting it are not making money but it almost never work the way they...
Jul 27, 2022
K
Kagaho
replied to the thread
Kintor Pharma Announces Dosing of First Subject in US Phase I Clinical Trial of GT20029 for Androgenic Alopecia and Acne
.
Some more info from Kintor latest presentation: "Advantage of AR-PROTAC (GT20029) - No skin permeation due to the drug’s physical...
Jul 27, 2022
K
Kagaho
replied to the thread
Kintor has started Phase 3 trial in China for Pyrilutamide
.
Kintor update from 7/15 "Pyrilutamide (KX-826) for topical use is anticipated to have minimal systemic exposure, thereby eliminating...
Jul 27, 2022
K
Kagaho
replied to the thread
The Group Buy to End All Group Buys: Twist1 Inhibitor
.
It would be so nice to see one of this experimental small new molecules being disruptive. Good luck to those using this stuff. Make sure...
Jul 25, 2022
K
Kagaho
replied to the thread
Follica Microneedling Protocol Patent Disclosed
.
Dude, im dissappointed at Follica too. Its way too easy to cite someone 10 later saying they were wrong. Im still grateful to...
Jul 22, 2022
K
Kagaho
reacted to
InBeforeTheCure's post
in the thread
HDAC 4 Is most likely the cause of our suffering
with
Like
.
Found a balding guy with a deletion in TWIST1. (source)
Jul 19, 2022
K
Kagaho
replied to the thread
Anything better than Dutasteride by 2030?
.
Wait!! You didnt say if its topical or oral. Damn...
Jul 7, 2022
Home
Members
Quick note from the Forum Admin:
View Thread
.
Top